Journal
/
Recherche en cancérologie
/
EGFR-Mutant NSCLC Hasta Kaynaklı Organoidlerde Hedefe Yönelik Tedavilere Duyarlılığın Profillenmesi
Journal JoVE
Recherche en cancérologie
This content is Free Access.
Journal JoVE Recherche en cancérologie
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Please note that all translations are automatically generated. Click here for the English version.

EGFR-Mutant NSCLC Hasta Kaynaklı Organoidlerde Hedefe Yönelik Tedavilere Duyarlılığın Profillenmesi

3,526 Views

•

08:52 min

•

November 22, 2021

DOI:

10.3791/63039-v

DOI:
10.3791/63039-v

•

08:52 min
November 22, 2021

•

6 Views
, , ,
1Department of Medicine,University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center,University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology,University of California, San Francisco

Summary

Automatically generated

Bu protokol, NSCLC hasta kaynaklı organoid modellerde hedeflenen sinyal inhibitörlerine karşı ilaç duyarlılıklarının standartlaştırılmış bir değerlendirmesini açıklamaktadır.

Explore More Videos

OrganoidsEGFR-mutant NSCLCTargeted TherapiesMatrigelCell CultureDissociationTrypsinizationCentrifugationCell CountingCell Suspension96-well Plate

Read Article

Cite this Article

Barbosa Rabago, D., Blakely, C. M., Haderk, F., Bivona, T. G. Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids. J. Vis. Exp. (177), e63039, doi:10.3791/63039 (2021).

Download .ris file

Copy

Share Video

.

Copy